Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 5101–5150 of 18416
On May 14, 2024, James Kellogg, the Chief Financial Officer (“CFO”) of the Company, provided a letter of resignation as CFO of the Company, effective as of May 14, 2024.
Venkatesh Nathamuni has been appointed Executive Vice President and Chief Financial Officer of the Company, effective as of June 3, 2024
On May 11, 2024, Venk Nathamuni provided Cirrus Logic, Inc. (the “Company”) with notice of his intent to resign from his position as Chief Financial Officer effective May 24, 2024.
the Company’s Board of Directors appointed Ulf Habermann, the Company’s current Principal Accounting Officer, as interim Chief Financial Officer effective upon Mr. Nathamuni’s resignation and until a successor is appointed.
succeeding Damon Audia who has served in that role since September 2023. Mr. Audia will continue to serve in his role as Senior Vice President and Chief Financial Officer.
Effective on May 14, 2024, EMCORE Corporation (the “Company”) appointed Matthew Vargas as interim Principal Executive Officer.
Effective as of June 17, 2024, Austin Harbour, 43, will serve as the Chief Financial Officer of the Company.
Lance Turner, the Chief Financial Officer, will resign from the Company, effective June 17, 2024.
David Keffer, Corporate Vice President and Chief Financial Officer, will be retiring from the Company. Mr. Keffer will step down from his position on October 1, 2024, but will remain an employee of the Company until his retirement from the Company on February 21, 2025 to help facilitate an orderly transition.
The Company announced that Kenneth Crews was elected Corporate Vice President and Chief Financial Officer effective October 1, 2024.
Peter B. Crawford notified the Company of his intent to retire from his Managing Director and Chief Financial Officer position at the Company following a planned transition period with the effective date of his retirement to be determined in the future.
the Board of Directors of Aileron Therapeutics, Inc. (the “Company”) appointed Timothy M. Cunningham, a consultant at Danforth Advisors, LLC (“Danforth”), as interim chief financial officer, effective as of May 16, 2024.
Mr. Garner's departure from the Company on May 15, 2024.
On May 11, 2024, Daniel Tempesta notified Cerence Inc. (the “Company”) of his decision to resign as Chief Financial Officer of the Company for personal reasons, effective as of May 17, 2024.
The Board of Directors of the Company has designated Stefan Ortmanns, President and Chief Executive Officer, as the Company’s principal financial officer, and Katherine Roman, Vice President and Corporate Controller, as the Company’s principal accounting officer, each on an interim basis and effective as of May 17, 2024.
On May 15, 2024, Leonardo Fernandes, the Chief Financial Officer of Spectaire Holdings Inc. (the “Company”) tendered his resignation as the Company’s Chief Financial Officer, including any positions held with any of the Company’s subsidiaries, effective May 15, 2024.
In connection with and effective as of Mr. Spierto’s appointment as Chief Accounting Officer, Briony R. Quinn, the Company’s Executive Vice President, Chief Financial Officer and Treasurer, will no longer serve as principal accounting officer.
Effective May 9, 2024, Douglas Smith was given notice of his separation from The Arena Group Holdings, Inc (the “Company”).
On May 16, 2024, AEON Biopharma, Inc. (“AEON” or the “Company”) terminated the Consulting Agreement (the “Agreement”) between AEON and Peter Reynolds, which has resulted in his termination as the Chief Financial Officer, principal financial officer and principal accounting officer of the Company effective as of May 17, 2024.
On May 16, 2024, our Board of Directors appointed Marc Forth, age 53, as our principal financial officer, effective as of May 17, 2024.
On May 11, 2024, as part of its succession plan for Mr. Ballschmiede’s role, the Company’s Board of Directors appointed Sharon R. Villaverde as CFO and CAO and the Company’s principal financial officer and principal accounting officer, effective May 13, 2024 (the “Effective Date”).
On February 12, 2024, Ronald A. Ballschmiede, Executive Vice President, Chief Financial Officer (“CFO”) and Chief Accounting Officer (“CAO”) and the Company’s principal financial officer and principal accounting officer of Sterling Infrastructure, Inc. (the “Company”), notified the Company of his plan to retire in 2024.
Effective June 1, 2024, Dr. Srinivas Rao was appointed the Company's Co-Chief Executive Officer and designated as co-principal executive officer.
Mr. Brand will serve as Co-Chief Executive Officer of the Company from June 1, 2024 through December 31, 2024
at which time he will be stepping down from his position as the Company's Chief Executive Officer
Mr. Heckes also ceased serving as President and Chief Executive Officer of Masonite.
Effective May 13, 2024, Messrs. Berner and McKinney stepped down as executive officers of the Company, and the following individuals became the executive officers of the Company, with the respective position(s) set forth in the table below: Name Position Richard O’Dell Chief Executive Officer
On May 15, 2024, Jeffrey Painter announced his plans to retire from his position as Chief Executive Officer and President of Cardinal Ethanol, LLC
The Board of Directors of Pulse Biosciences, Inc. (the “Company”) has appointed Burke T. Barrett as President and Chief Executive Officer of the Company and as a director, in each case effective as of May 12, 2024
On May 13, 2024, Starlette B. Johnson, Interim Chief Executive Officer of Rocky Mountain Chocolate Factory, Inc. (the “Company”) and member of the Company’s Board of Directors (the “Board”), resigned from her position as Interim Chief Executive Officer effective immediately.
On May 14, 2024, the Board appointed Jeffrey R. Geygan, Chairman of the Board, as Interim Chief Executive Officer, effective immediately.
the board of directors (the “ Board ”) of the Company announced that it appointed Paul Gohr, age 42, as Chief Financial Officer of the Company, effective May 16, 2024
the Company announced that Stephanie Hogue, the Company’s current President, Chief Financial Officer, Secretary and Treasurer, resigned from her role as Chief Financial Officer of the Company, effective as of the Effective Date.
On May 14, 2024, the board of directors (the “Board”) of the Company appointed David Desharnais as Chief Executive Officer of the Company, effective May 16, 2024.
Mr. Desharnais will succeed Robert A. Berman, who will cease to serve as the Chief Executive Officer of the Company effective May 16, 2024.
The Board announced that it will appoint Joseph Ruzynski as Chief Executive Officer, effective July 1, 2024
Mr. Knapper will resign from his position as President and Chief Executive Officer of the Company, effective as of December 31, 2024.
the Board of Directors unanimously appointed John D. Baker III as the Company’s Chief Executive Officer, effective immediately
John D. Baker II, Chief Executive Officer and Chairman of the Board of Directors of FRP Holdings, Inc. (the “ Company ”) announced his retirement from his position as Chief Executive Officer, effective immediately.
the Board of Directors unanimously appointed Matthew C. McNulty as the Company’s Chief Financial Officer. His employment will be effective May 31, 2024.
the Board of Directors of the Company approved the appointment of Staci Woolsey as the Company’s Executive Vice President, Chief Financial Officer effective September 16, 2024.
Lisa Curtis notified Granite Construction Incorporated (the “Company”) that she will retire as the Company’s Executive Vice President, Chief Financial Officer on September 16, 2024.
The Company and Berkshire Bank have appointed Brett Brbovic, age 43, as Executive Vice President and Chief Financial Officer, effective June 14, 2024.
R. David Rosato, Chief Financial Officer of the Company and the Bank, has decided to step down to pursue other interests.
Randall C. Schatzman, Ph.D. is stepping down as the Company’s Chief Executive Officer and has resigned as a member of the Board, both effective as of May 15, 2024.
The Board of Directors ("Board") of Saia, Inc. (the "Company") has appointed Matthew Batteh, age 35, as the Executive Vice President and Chief Financial Officer and Secretary of the Company, effective May 13, 2024.
Mr. Batteh is replacing Douglas L. Col who previously announced his retirement.
On May 11, 2024, the Board of Directors ("Board") of Viracta Therapeutics, Inc. (the "Company") appointed Michael Faerm to serve as the Company’s Chief Financial Officer, effective May 13, 2024
the Board appointed Suhail A. Shaikh as Chief Executive Officer of the Company, effective immediately.
Effective upon Mr. Rizvi’s departure, Jack Pacheco, the Company’s former CFO and current chief operating officer and president of Memory Solutions, will assume the role of interim CFO and serve as the Company’s principal financial and accounting officer on an interim basis until the Company appoints a permanent successor.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.